Logo - springer
Slogan - springer

Springer Gabler - Management - Health Care | Creating R&D Incentives for Medicines for Neglected Diseases - An Economic Analysis of Parallel

Creating R&D Incentives for Medicines for Neglected Diseases

An Economic Analysis of Parallel Imports, Patents, and Alternative Mechanisms to Stimulate Pharmaceutical Research

Müller-Langer, Frank

2009, XIX, 297p. 8 illus..

Available Formats:

Springer eBooks may be purchased by end-customers only and are sold without copy protection (DRM free). Instead, all eBooks include personalized watermarks. This means you can read the Springer eBooks across numerous devices such as Laptops, eReaders, and tablets.

You can pay for Springer eBooks with Visa, Mastercard, American Express or Paypal.

After the purchase you can directly download the eBook file or read it online in our Springer eBook Reader. Furthermore your eBook will be stored in your MySpringer account. So you can always re-download your eBooks.


(net) price for USA

ISBN 978-3-8349-8323-7

digitally watermarked, no DRM

Included Format: PDF

download immediately after purchase

learn more about Springer eBooks

add to marked items


Softcover (also known as softback) version.

You can pay for Springer Books with Visa, Mastercard, American Express or Paypal.

Standard shipping is free of charge for individual customers.


(net) price for USA

ISBN 978-3-8349-1730-0

free shipping for individuals worldwide

usually dispatched within 3 to 5 business days

add to marked items

Virtually no research is targeted at developing medicines for tropical diseases as the expected market returns from R&D into these diseases in the private pharmaceuticals sector are too low. Frank Müller-Langer addresses the market failure with respect to R&D for medicines for tropical diseases and the lack of short-term access to affordable medicines in poor countries. The author analyzes additional push and pull mechanisms to stimulate R&D for pharmaceutical products alongside patent protection which may help mitigate the problem of those consumers in poor countries who lack access to affordable medicines. Furthermore, he reasons that a global regime of banning parallel trade from low-income countries to high-income countries is desirable from a developing country’s perspective.

Content Level » Research

Keywords » Forschung & Entwicklung - Forschung und Entwicklung - Innovation - Medicines - Patente - Patents - R&D

Related subjects » Health Care - Management

Table of contents 

The TRIPS Agreement and Access to Patented Medicines; Economic Analysis of Patents ; Patent Protection in the Developing World; Legal und Economic Analysis of Parallel Imports; Solutions for the Problem of Underinvestment in R&D for Medicines for Neglected Infectious and Tropical Diseases

Popular Content within this publication 



Read this Book on Springerlink

Services for this book

New Book Alert

Get alerted on new Springer publications in the subject area of Health Economics.